Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Necrotizing Soft Tissue Infection clinical trials
4 of 4 indexed Necrotizing Soft Tissue Infection trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 4 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Necrotizing Soft Tissue Infection: 4 US clinical trials tracked, 4 recruiting.
Necrotizing Soft Tissue Infection is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is Aroa Biosurgery Limited, running 1 of these trials.
Enrollment posture brief
Registry condition necrotizing-soft-tissue-infection
OPEN 4 | RECR 100% | LATE 0 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Necrotizing Soft Tissue Infection lists 4 open slots (100% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Necrotizing Soft Tissue Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Necrotizing Soft Tissue Infection is recruiting above its size-band peers.
4 of 4 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Myriad™ Augmented Soft Tissue Reconstruction Registry
Aroa Biosurgery Limited
NCT05243966
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
Washington University School of Medicine
NCT03482245
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
University of California, Irvine
NCT06002607
The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®
Benjamin T. Miller
NCT06857708
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Necrotizing Soft Tissue Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Necrotizing Soft Tissue Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Necrotizing Soft Tissue Infection page
4 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Necrotizing Soft Tissue Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Aroa Biosurgery Limited sponsors the most Necrotizing Soft Tissue Infection trials on record, review their full trial history before evaluating a specific study. See Aroa Biosurgery Limited's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Necrotizing Soft Tissue Infection condition card totals 4 registered trials; most-linked intervention Myriad Matrix™ and Myriad Morcells™; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.